Literature DB >> 32476859

The indications for the treatment of sarcoidosis: Wells Law.

Robert P Baughman1, Marc A Judson2, Athol Wells3.   

Abstract

Entities:  

Year:  2017        PMID： 32476859      PMCID： PMC7170078          DOI： 10.36141/svdld.v34i4.6957

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN： 1124-0490            Impact factor:   0.670


× No keyword cloud information.
  30 in total

1.  Stage IV sarcoidosis: comparison of survival with the general population and causes of death.

Authors:  A Nardi; P-Y Brillet; P Letoumelin; F Girard; M Brauner; Y Uzunhan; J-M Naccache; D Valeyre; H Nunes
Journal:  Eur Respir J       Date:  2011-11-10       Impact factor: 16.671

2.  Chronic pulmonary aspergillosis complicating sarcoidosis.

Authors:  Yurdagül Uzunhan; Hilario Nunes; Florence Jeny; Maxime Lacroix; Sophie Brun; Pierre-Yves Brillet; Emmanuel Martinod; Marie-France Carette; Diane Bouvry; Caroline Charlier; Fanny Lanternier; Carole Planès; Abdellatif Tazi; Olivier Lortholary; Robert P Baughman; Dominique Valeyre
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

3.  Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.

Authors:  A Pietinalho; P Tukiainen; T Haahtela; T Persson; O Selroos
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

4.  Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment.

Authors:  Marjon D Elfferich; Patty J Nelemans; Rudolf W Ponds; Jolanda De Vries; Petal A Wijnen; Marjolein Drent
Journal:  Respiration       Date:  2010-04-29       Impact factor: 3.580

5.  Presentation of sarcoidosis and outcome of pulmonary changes.

Authors:  F K Rømer
Journal:  Dan Med Bull       Date:  1982-01

6.  Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis.

Authors:  A Baydur; M Alsalek; S G Louie; O P Sharma
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

7.  The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.

Authors:  Marc A Judson; Haroon Chaudhry; Amanda Louis; Kevin Lee; Recai Yucel
Journal:  Respir Med       Date:  2015-02-07       Impact factor: 3.415

8.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

9.  Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Respir Med       Date:  2013-10-22       Impact factor: 3.415

10.  Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Authors:  Athénaïs Boucly; Vincent Cottin; Hilario Nunes; Xavier Jaïs; Abdelatif Tazi; Grégoire Prévôt; Martine Reynaud-Gaubert; Claire Dromer; Catherine Viacroze; Delphine Horeau-Langlard; Christophe Pison; Emmanuel Bergot; Julie Traclet; Jason Weatherald; Gérald Simonneau; Dominique Valeyre; David Montani; Marc Humbert; Olivier Sitbon; Laurent Savale
Journal:  Eur Respir J       Date:  2017-10-19       Impact factor: 16.671
View more
  2 in total

1.  Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study.

Authors:  Rachel Strykowski; Divya C Patel; Manny Ribeiro Neto; Kerry M Hena; Mridu Gulati; LIsa A Maier; Karen Patterson
Journal:  BMJ Open Respir Res       Date:  2022-07

Review 2.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.